Emerg Infect Dis by Noya-Alarc\uf3n, Oscar et al.
Acknowledgment
We thank Carolien Flemming for excellent support with  
diagnostic microbiology.
About the Author
Dr. Sleutjens is an equine ambulatory veterinarian. Her research 
interest is the effects of head and neck position on the welfare of 
the equine athlete.
References
  1. Eyre DW, Kenkre JS, Bowler ICJW, McBride SJ.  
Streptococcus equi subspecies zooepidemicus meningitis—a case 
report and review of the literature. Eur J Clin Microbiol Infect Dis. 
2010;29:1459–63. http://dx.doi.org/10.1007/s10096-010-1037-5
  2. Minces LR, Brown PJ, Veldkamp PJ. Human meningitis from 
Streptococcus equi subsp. zooepidemicus acquired as zoonoses. 
Epidemiol Infect. 2011;139:406–10. http://dx.doi.org/10.1017/
S0950268810001184
  3. Altreuther M, Lange C, Myhre HO, Hannula R. Aortic graft  
infection and mycotic aneurysm with Streptococcus equi  
zooepidemicus: two cases with favorable outcome of antibiotic 
treatment. Vascular. 2013;21:6–9. http://dx.doi.org/10.1258/
vasc.2011.cr0299
  4. van Samkar A, Brouwer MC, van der Ende A, van de Beek D. 
Streptococcus equi meningitis. Clin Microbiol Infect. 2016;22:e3–
4. http://dx.doi.org/10.1016/j.cmi.2015.09.003
  5. Kittang BR, Pettersen VK, Oppegaard O, Skutlaberg DH, Dale H, 
Wiker HG, et al. Zoonotic necrotizing myositis caused by  
Streptococcus equi subsp. zooepidemicus in a farmer. BMC Infect 
Dis. 2017;17:147. http://dx.doi.org/10.1186/s12879-017-2262-7
  6. Fulde M, Valentin-Weigand P. Epidemiology and pathogenicity  
of zoonotic streptococci. In: Chhatwal G, editor. Current Topics  
in Microbiology and Immunology. New York: Springer;2012.  
p. 49–81.
  7. Björnsdóttir S, Harris SR, Svansson V, Gunnarsson E,  
Sigurðardóttir ÓG, Gammeljord K, et al. Genomic dissection of an 
Icelandic epidemic of respiratory disease in horses and associated 
zoonotic cases. MBiol. 2017;8:e00826–17.
  8. Pelkonen S, Lindahl SB, Suomala P, Karhukorpi J, Vuorinen S, 
Koivula I, et al. Transmission of Streptococcus equi subspecies 
zooepidemicus infection from horses to humans. Emerg Infect Dis. 
2013;19:1041–8. http://dx.doi.org/10.3201/eid1907.121365
Address for correspondence: Janneke Sleutjens, Utrecht University, 
Department of Equine Sciences, Faculty of Veterinary Medicine, Yalelaan 
112, 3584 CM Utrecht, the Netherlands; email: j.sleutjens@uu.nl
182 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 1, January 2019
RESEARCH LETTERS
Trachoma in 3 Amerindian 
Communities, Venezuelan 
Amazon, 2018
Oscar Noya-Alarcón, Maríapía Bevilacqua, 
Alfonso J. Rodríguez-Morales
Author affiliations: Universidad Central de Venezuela, Caracas, 
Venezuela (O. Noya-Alarcón); Asociación Venezolana para la 
Conservación de Áreas Naturales, Caracas (M. Bevilacqua); 
Universidad Tecnológica de Pereira, Pereira, Colombia  
(A.J. Rodríguez-Morales); Universidad Privada Franz Tamayo, 
Cochabamba, Bolivia (A.J. Rodríguez-Morales)
DOI: https://doi.org/10.3201/eid2501.181362
Trachoma is among the most common infectious causes of 
blindness. During January–May 2018, a total of 4 trachoma 
cases were diagnosed among Amerindians of the Yanoma-
mi ethnic group in 3 communities of southern Venezuela. 
This country has social and environmental conditions con-
ducive to the endemicity of this neglected tropical disease.
Trachoma, caused by the bacterium Chlamydia trachoma-tis, is the most common infectious cause of blindness. It is 
endemic to many of the poorest and most remote areas of Af-
rica, Asia, Australia, the Middle East, and Latin America (1). 
Trachoma causes visual impairment in ≈2.2 million persons 
worldwide, of whom 1.2 million are completely blind (2). As 
of April 2018, ≈158 million persons living in districts to which 
trachoma is endemic are at risk (3). In South America, tracho-
ma is considered endemic to Brazil (4) and Colombia (5) but 
not to Venezuela. We describe 4 patients in whom trachoma 
was diagnosed during January–May 2018 in 3 communities 
in the Amazon region of southern Venezuela. All were Am-
erindians of the Yanomami ethnic group living near rivers in 
extensive, well-conserved international forest frontiers.
During January–May 2018, in the integrated healthcare 
system in the Venezuela states of Amazonas and Bolivar, 4 
trachoma cases were detected. Two cases occurred in the Ya-
nomami community of Kuyuwiniña, Alto Caura River ba-
sin, Bolivar, and 1 case occurred in each of 2 communities 
of the upper Orinoco River basin of Amazonas (Oroshi and 
Rashakami) (Appendix Figure 1, https://wwwnc.cdc.gov/
EID/article/25/1/18-1362-App1.pdf).
Case-patient 1 was a 38-year-old woman from Oroshi 
with a 5-month history of trachomatous trichiasis (TT), pain, 
madarosis, blepharitis, and conjunctivitis in both eyes. Case-
patient 2 was a 35-year-old woman from Kuyuwiniña with a 
6-month history of TT, pain, madarosis, blepharitis, and con-
junctivitis in both eyes; corneal opacity in the right eye; and 
full blindness in the left eye (Appendix Figure 2). Case-pa-
tient 3 was a 45-year-old man from Kuyuwiniña with a 5-year 
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history of TT, madarosis, blepharitis, conjunctivitis, and cor-
neal opacity in both eyes. Case-patient 4 was a 22-year-old 
man from Rashakami with a 1-year history of TT, madarosis, 
blepharitis, and keratitis in both eyes; full blindness in the left 
eye; and decreased vision in the right eye. 
All 4 patients used natural depilatory wax to improve their 
trachoma. No additional information on use of traditional eye 
medicine or epilation was obtained. These communities have 
no access to potable water except rivers and live crowded in 
open aboriginal community households (Appendix Figure 1, 
panel B). These patients were treated with azithromycin (1 
g single dose orally) and showed clinical improvement (less 
inflammation) 3 months later (6) without surgery.
Trachoma is a neglected tropical disease (NTD) that 
disproportionately affects the poorest communities (7). 
Worldwide, many indigenous peoples are at risk (4,5,7). 
The geographic origin of these cases is unknown. In remote 
areas of the southern Venezuelan Amazon, the population 
moves within the Caura River basin and in the upper Ori-
noco basin and to and from Brazil in the headwaters of the 
Auaris River and other subbasins of the Branco River in 
Yanomami territory. The potential introduction of infected 
illegal gold miners also should be considered as a source 
of trachoma. The remoteness of these communities often 
means they have limited access to healthcare, making as-
sessment of trachoma and other diseases challenging. Thus, 
findings of this NTD and others is not surprising. 
Trachoma was originally reported in Venezuela in 
1894; at least 17 cases were sporadically reported during 
1903–1956. In 1982, six case-patients (2 female, 4 male) 
30 months–22 years of age were described (8).
A resolution of the World Health Assembly in 1998 
established political commitment for global elimination 
of trachoma as a public health problem. Much progress is 
being made toward that goal, but momentum may be in-
sufficient to meet the 2020 target (1), particularly given 
emerging evidence of previously unknown endemic foci 
in places such as Venezuela and the Democratic Republic 
of the Congo. Population-based studies are needed to de-
fine the prevalence of trachoma in these communities of 
Venezuela, which border Brazil, a country in which this 
NTD is endemic in indigenous populations, with reported 
prevalences of up to 35.2% for the trachomatous follicular 
inflammation in children 1–9 years of age (4).
Water is necessary for face washing, and trachoma often 
occurs in communities or households without an adequate 
water supply. Several studies have identified a positive as-
sociation between the distance to the water source and the 
prevalence of active trachoma (1). Because of improvement 
of socioeconomic and sanitary status (9), advent of new 
generations of antimicrobial drugs, and training of oph-
thalmologists and eye-care facilities, the prevalence of tra-
choma is decreasing (2). In the context of the onchocerciasis 
elimination program in the area, ophthalmologists and other 
specially trained physicians periodically attended these pop-
ulations to assess visual health, including onchocercosis. In 
countries such as Brazil (4) and Colombia (5), trachoma ap-
pears to be a serious public health problem in indigenous 
settlements and should be prioritized in programs aimed at 
eliminating trachoma (1,2,7). The cases we report suggest 
that national and international health authorities should con-
sider developing surveillance and undertaking research for 
trachoma in these areas of Venezuela (6,10).
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